Our Pricing

Mounjaro vs Saxenda Single Pen - Choose Your Dose

Published on: June 03, 2026

Choosing between mounjaro vs saxenda single pen uk options requires understanding how each medication works, their dosing schedules, and which aligns with your weight loss goals. At Cured Pharmacy, we offer both treatments with transparent upfront pricing, free clinical consultations under three minutes, and expert guidance from our UK-registered clinical team led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

Understanding Mounjaro vs Saxenda: Key Differences

Mounjaro (tirzepatide) and Saxenda (liraglutide) are both injectable weight loss medications licensed by the MHRA in the UK, but they work through fundamentally different mechanisms. Mounjaro is the first dual GIP/GLP-1 receptor agonist, activating two natural hormone pathways that regulate appetite and blood sugar metabolism [1]. Saxenda, by contrast, is a single GLP-1 receptor agonist that has been available in the UK since 2015 [2].

The dual-action mechanism of Mounjaro has demonstrated superior weight loss outcomes in head-to-head clinical trials. In the SURPASS-2 study, participants on tirzepatide 15mg achieved an average 12.4kg weight reduction compared to 6.2kg with semaglutide 1mg over 40 weeks [1]. Saxenda clinical trials showed average weight loss of 8-9% of initial body weight over 56 weeks [2].

Dosing frequency differs significantly between the two treatments. Mounjaro requires one subcutaneous injection per week, whilst Saxenda must be administered daily. This weekly versus daily schedule often influences patient preference and long-term adherence, particularly for those with busy lifestyles or needle anxiety.

Mounjaro Single Pen Dosing and Titration

Each Mounjaro KwikPen contains four doses of the same strength, designed for once-weekly administration. The standard UK titration schedule begins at 2.5mg weekly for four weeks, then increases to 5mg for the next four weeks [3]. Your prescriber may continue escalating the dose every four weeks (7.5mg, 10mg, 12.5mg, up to a maximum of 15mg) based on your weight loss response and tolerability.

Single-pen purchasing allows flexibility during the initial titration phase. Some patients experience significant weight loss and appetite suppression at lower doses and may not require escalation to higher strengths. Others benefit from gradual dose increases to optimise results whilst minimising gastrointestinal side effects such as nausea or diarrhoea [3].

At Cured Pharmacy, Mounjaro starts from £124.99 per pen, with pricing varying by prescribed strength. All prescriptions require a free online clinical assessment by a UK-registered prescriber, completed in under three minutes through our secure platform.

Who Should Consider Mounjaro?

Mounjaro is typically prescribed for adults with a BMI of 30 or above, or 27 or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [3]. The medication is contraindicated in pregnancy, for those with a personal or family history of medullary thyroid carcinoma, and in patients with multiple endocrine neoplasia syndrome type 2. Your UK prescriber will assess your full medical history during consultation to ensure suitability.

Saxenda Single Pen Dosing and Daily Use

Saxenda pens contain 18mg of liraglutide and are designed for daily subcutaneous injection. The standard UK titration schedule begins at 0.6mg daily for the first week, increasing by 0.6mg each week until reaching the maintenance dose of 3mg daily by week five [2]. Each pen delivers 30 doses when used at the 0.6mg level, but fewer doses at higher strengths.

The daily injection requirement means patients need a consistent routine and must plan for regular pen replacements. A single Saxenda pen typically lasts six days once the maintenance dose of 3mg is reached. This differs markedly from the weekly convenience of Mounjaro, though some patients prefer the daily dosing as it provides more frequent reinforcement of their weight loss commitment [4].

Saxenda is priced from £135.00 at Cured Pharmacy, making it a lower initial investment compared to weekly injectable alternatives. However, the daily dosing requirement means monthly costs should be calculated based on the number of pens needed to maintain your prescribed dose. Your UK prescriber will provide a clear treatment plan during your free consultation.

Who Should Consider Saxenda?

Saxenda is licensed for adults with a BMI of 30 or above, or 27 or above with weight-related comorbidities [2]. It has a longer track record in UK clinical practice than Mounjaro, with extensive real-world safety data accumulated since 2015. Patients who prefer daily dosing for psychological reinforcement, those who have previously used GLP-1 medications, or individuals seeking a lower starting price point may find Saxenda well-suited to their needs. As with all prescription treatments, suitability is determined by a UK prescriber following clinical assessment.

Side Effects: What to Expect with Each Treatment

Both Mounjaro and Saxenda belong to the incretin mimetic class and share a similar side effect profile, with gastrointestinal symptoms being most common. Nausea, diarrhoea, constipation, vomiting, and abdominal discomfort affect approximately 20-40% of patients during initial titration [1][2]. These effects typically diminish as your body adjusts to the medication, particularly when dose escalation follows the recommended schedule.

Mounjaro's weekly dosing may produce a more gradual onset of side effects compared to Saxenda's daily injections, though individual experiences vary considerably. In SURPASS trials, discontinuation rates due to adverse events ranged from 4.3% to 7.1% across different tirzepatide doses [1]. Saxenda trials reported discontinuation rates of approximately 9.9% due to gastrointestinal side effects [2].

Serious but rare side effects include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking other glucose-lowering medications). Both medications carry a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [3][4]. Report any severe abdominal pain, persistent vomiting, or signs of allergic reaction to your prescriber immediately.

Clinical Evidence: Mounjaro vs Saxenda Effectiveness

Direct comparison trials between tirzepatide and liraglutide are limited, but individual trial data provides clear efficacy benchmarks. The SURMOUNT-1 trial demonstrated that participants on tirzepatide 15mg achieved an average 22.5% reduction in body weight over 72 weeks [5]. The SCALE Obesity and Prediabetes trial showed liraglutide 3mg (Saxenda) produced an average 8% body weight reduction over 56 weeks [2].

These results suggest Mounjaro may deliver approximately 2.5 to 3 times greater weight loss than Saxenda in clinical trial populations, though real-world outcomes depend on individual factors including baseline BMI, adherence, dietary modifications, and physical activity levels [5][2]. Neither medication is a standalone solution—both work optimally when combined with a reduced-calorie diet and increased exercise programme.

Cardiovascular outcomes data exists for liraglutide, with the LEADER trial demonstrating reduced risk of major adverse cardiovascular events in patients with type 2 diabetes [6]. Tirzepatide cardiovascular outcomes trials are ongoing, with results expected in the coming years. Your UK prescriber will consider your complete medical profile, including cardiovascular risk factors, when recommending treatment.

Long-Term Weight Maintenance Considerations

Both medications require ongoing use to maintain weight loss, with clinical evidence showing significant weight regain after discontinuation [5][2]. Treatment duration should be discussed with your prescriber based on your weight loss goals, response to therapy, and tolerance of side effects. NICE guidance recommends discontinuing treatment if less than 5% weight loss is achieved after 12 weeks at the maintenance dose, though individual clinical circumstances may warrant different approaches.

Choosing Between Mounjaro and Saxenda Single Pens

Your decision between Mounjaro and Saxenda should be guided by several factors: your weight loss goals, tolerance for injection frequency, budget considerations, previous experience with GLP-1 medications, and your prescriber's clinical recommendation. Patients seeking maximum weight loss efficacy and who prefer weekly dosing may find Mounjaro more suitable, whilst those wanting a lower initial cost with established long-term safety data may prefer Saxenda.

Single-pen purchasing offers flexibility during the initial treatment phase. You can assess your response to the starting dose, evaluate side effect tolerance, and adjust your treatment plan with your prescriber before committing to larger quantities. This approach is particularly valuable for first-time users of injectable weight loss medications who want to ensure compatibility before long-term commitment.

At Cured Pharmacy, our UK-registered clinical team provides personalised guidance during your free consultation. Superintendent Pharmacist Tarun Kumar and our prescribers assess your medical history, current medications, weight loss objectives, and lifestyle factors to recommend the most appropriate treatment. All consultations are conducted securely online, typically completed in under three minutes, with discreet packaging and genuine UK-licensed medicines guaranteed.

Starting Your Weight Loss Journey at Cured Pharmacy

Begin by completing our confidential online consultation, which covers your medical history, current health status, previous weight loss attempts, and treatment preferences. A UK-registered prescriber will review your assessment, and if approved, your medication is dispensed by our GPhC-registered pharmacy (9012511) with discreet next-day delivery available. We offer transparent upfront pricing with no hidden consultation fees—the price you see is the price you pay. Our clinical team remains available for ongoing support throughout your treatment journey.

Scientific References

1. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
2. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen – Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14298 [accessed 13 August 2026]
4. Electronic Medicines Compendium. (2023). Saxenda 6 mg/ml solution for injection in pre-filled pen – Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/2313 [accessed 13 August 2026]
5. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
6. Marso, S. P., Daniels, G. H., Brown-Frandsen, K., et al. (2016). Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine, 375(4), 311–322. https://doi.org/10.1056/NEJMoa1603827 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and lifestyle changes.